ANDREW S. MASLAN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Nuo Therapeutics, Inc.

Filing Date Source Excerpt
2010-05-27 Andrew Maslan, our Chief Financial Officer, were among the Purchasers in the April 2010 Offering.
2012-04-16 (9) Chief Financial Officer of the Company. Includes 367,275 shares Mr. Maslan may acquire upon the exercise of stock options approved by the Board and issued under the Company’s Long-Term Incentive Plan and warrants.
2012-08-20 Andrew S. Maslan ... Age 42 ... Office Held Chief Financial Officer ... Andrew S. Maslan ... Chief Financial Officer ... Total ... 247,426
2013-04-26 "(9) Includes 401,218 shares Mr. Maslan may acquire upon the exercise of stock options approved by the Board and issued under the Company’s Long-Term Incentive Plan and warrants. Mr. Maslan tendered his resignation as the Company’s Chief Financial Officer on March 29, 2013, effective as of May 10, 2013."

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-05-13